Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jame Abraham

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Seminars in Oncology|February 25, 2014
Introduction and commentary: paving the way for biosimilars in oncology, part 2: focus on safety and clinical trial considerationsJame Abraham
Seminars in Oncology|April 29, 2014
Introduction and commentary: Paving the way for biosimilars in oncology, part 3: Clinical and economic impact of oncology biosimilarsJame Abraham
Seminars in Oncology|November 26, 2013
Developing oncology biosimilars: an essential approach for the futureJame Abraham
Expert Review of Anticancer Therapy|October 14, 2014
PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?Jame Abraham
Seminars in Oncology|November 26, 2013
Introduction and commentary: Paving the way for biosimilars in oncologyJame Abraham
The Breast Journal|September 13, 2003
Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literatureRamin Altaha, Jame Abraham
Journal of Oncology Practice|March 13, 2018
Management of Chemotherapy-Induced Alopecia With Scalp CoolingMegan Kruse, Jame Abraham
Seminars in Oncology|July 7, 2020
Advances in Care of the Breast Cancer PatientMegan Kruse, Jame Abraham
JCO Oncology Practice|February 2, 2021
Reflection on Supportive Care Elements During the Metastatic Breast Cancer JourneyErin Roesch, Jame Abraham
The Journal of Community and Supportive Oncology|June 28, 2014
Obinutuzumab for previously untreated chronic lymphocytic leukemiaJame Abraham, Mark Stegner
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Seminars in Oncology|February 25, 2014
Introduction and commentary: paving the way for biosimilars in oncology, part 2: focus on safety and clinical trial considerationsJame Abraham
Seminars in Oncology|April 29, 2014
Introduction and commentary: Paving the way for biosimilars in oncology, part 3: Clinical and economic impact of oncology biosimilarsJame Abraham
Seminars in Oncology|November 26, 2013
Developing oncology biosimilars: an essential approach for the futureJame Abraham
Expert Review of Anticancer Therapy|October 14, 2014
PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?Jame Abraham
Seminars in Oncology|November 26, 2013
Introduction and commentary: Paving the way for biosimilars in oncologyJame Abraham
The Breast Journal|September 13, 2003
Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literatureRamin Altaha, Jame Abraham
Journal of Oncology Practice|March 13, 2018
Management of Chemotherapy-Induced Alopecia With Scalp CoolingMegan Kruse, Jame Abraham
Seminars in Oncology|July 7, 2020
Advances in Care of the Breast Cancer PatientMegan Kruse, Jame Abraham
JCO Oncology Practice|February 2, 2021
Reflection on Supportive Care Elements During the Metastatic Breast Cancer JourneyErin Roesch, Jame Abraham
The Journal of Community and Supportive Oncology|June 28, 2014
Obinutuzumab for previously untreated chronic lymphocytic leukemiaJame Abraham, Mark Stegner
Pageof 15